BeOne Medicines Belgium

{
  "stage": null,
  "notary": {
    "name": "Stijn RAES",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-07-11",
    "filing_date": "2025-07-09",
    "act_kind_objet": "DENOMINATION, DIVERS"
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "act_date": "2025-06-20",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "1001.115.521",
        "name": "BeiGene Belgium",
        "role": "other",
        "address": "Rue aux Laines 70, 1000 Bruxelles",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": null,
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "1001.115.521",
    "name_full": "BeiGene Belgium",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "detected_kind_raw": "material_correction",
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Stijn RAES",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de BeiGene Belgium a adopt\u00E9 des r\u00E9solutions pour rectifier le nombre d\u0027actions mentionn\u00E9 dans l\u0027acte de constitution (de 1.000 \u00E0 100), modifier le nom de la soci\u00E9t\u00E9 en \u0022BeOne Medicines Belgium\u0022 \u00E0 partir du 15 juillet 2025, et conf\u00E9rer des pouvoirs \u00E0 l\u0027organe de gestion, au notaire, et \u00E0 des tiers pour l\u0027ex\u00E9cution des r\u00E9solutions.",
  "co_filed_documents": [
    "exp\u00E9dition de l\u0027acte",
    "statuts coordonn\u00E9s"
  ],
  "detected_real_type": "other",
  "referenced_correction": {
    "prior_pub_date": "2023-10-16",
    "what_corrected": "Correction of the number of shares mentioned under the title \u0027APPORTS - ACTIONS - SOUSCRIPTION\u0027 from 1,000 to 100.",
    "prior_pub_number": "23408099"
  },
  "should_reroute_to_category": null
}